32906 Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices 

Controlled 

substance Drug code Schedule 

Methylphenidate ..... 1724 II 

Amobarbital ............ 2125 II 

Pentobarbital .......... 2270 II 

Secobarbital ............ 2315 II 

Codeine .................. 9050 II 

Oxycodone ............. 9143 II 

Hydromorphone ...... 9150 II 

Hydrocodone .......... 9193 II 

Methadone .............. 9250 II 

Methadone intermediate.9254 II 

Morphine ................. 9300 II 

Oripavine ................ 9330 II 

Thebaine ................. 9333 II 

Opium tincture ........ 9630 II 

Oxymorphone ......... 9652 II 

The company plans to manufacture 

the listed controlled substances in bulk 

for sale to its customers. 

Dated: July 10, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–15138 Filed 7–13–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Cerilliant Corporation 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 15, 2018. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 15, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

delegated to the Assistant Administrator 

of the DEA Diversion Control Division 

(‘‘Assistant Administrator’’) pursuant to 

section 7 of 28 CFR part 0, appendix to 

subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on June 

12, 2018, Cerilliant Corporation, 811 

Paloma Drive, Suite A, Round Rock, 

Texas 78665 applied to be registered as 

an importer of the following basic 

classes of controlled substances: 

Controlled substance Drug code Schedule 

3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................. 1233 I 

Cathinone ........................................................................................................................................................................ 1235 I 

Methcathinone ................................................................................................................................................................. 1237 I 

4-Fluoro-N-methylcathinone (4–FMC) ............................................................................................................................. 1238 I 

Pentedrone (a-methylaminovalerophenone) ................................................................................................................... 1246 I 

Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I 

4-Methyl-N-ethylcathinone (4–MEC) ............................................................................................................................... 1249 I 

Naphyrone ....................................................................................................................................................................... 1258 I 

N-Ethylamphetamine ....................................................................................................................................................... 1475 I 

N,N-Dimethylamphetamine .............................................................................................................................................. 1480 I 

Fenethylline ..................................................................................................................................................................... 1503 I 

Methaqualone .................................................................................................................................................................. 2565 I 

JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .................................................................................................. 6250 I 

SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................ 7008 I 

5-Fluoro-UR-144 and XLR11 [1-(5-Fluoropentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .................. 7011 I 

AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................... 7012 I 

JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................... 7019 I 

AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................... 7023 I 

THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ................................................................... 7024 I 

AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ................. 7031 I 

ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. 7035 I

APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .............................................................. 7048 I 

JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .................................................................................................. 7081 I 

SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole .................................................................... 7104 I 

JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. 7118 I 

JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..................................................................................................... 7122 I 

UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ................................................................. 7144 I 

JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ....................................................................................................................... 7173 I 

JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .......................................................................................... 7200 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... 7201 I 

JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... 7203 I 

PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ................................................................................................. 7222 I 

5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................................ 7225 I 

Alpha-ethyltryptamine ...................................................................................................................................................... 7249 I 

Ibogaine ........................................................................................................................................................................... 7260 I 

CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ 7297 I 

CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .......................................... 7298 I 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices 32907 

Controlled substance Drug code Schedule 

Lysergic acid diethylamide .............................................................................................................................................. 7315 I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) .............................................................................................. 7348 I 

Marihuana ........................................................................................................................................................................ 7360 I 

Parahexyl ......................................................................................................................................................................... 7374 I 

Mescaline ......................................................................................................................................................................... 7381 I 

2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2) ........................................................................................... 7385 I 

3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 7390 I 

4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 7392 I 

4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 7395 I 

2,5-Dimethoxyamphetamine ............................................................................................................................................ 7396 I 

JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 7398 I 

3,4-Methylenedioxyamphetamine .................................................................................................................................... 7400 I 

5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7401 I 

N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7402 I 

3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 7404 I 

3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I 

4-Methoxyamphetamine .................................................................................................................................................. 7411 I 

5-Methoxy-N–N-dimethyltryptamine ................................................................................................................................ 7431 I 

Alpha-methyltryptamine ................................................................................................................................................... 7432 I 

Bufotenine ........................................................................................................................................................................ 7433 I 

Diethyltryptamine ............................................................................................................................................................. 7434 I 

Dimethyltryptamine .......................................................................................................................................................... 7435 I 

Psilocybin ......................................................................................................................................................................... 7437 I 

Psilocyn ........................................................................................................................................................................... 7438 I 

5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 7439 I 

N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 7455 I 

1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 7458 I 

1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 7470 I 

N-Benzylpiperazine .......................................................................................................................................................... 7493 I 

4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..................................................................................................... 7498 I 

2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) .................................................................................................. 7508 I 

2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E) ..................................................................................................... 7509 I 

2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ................................................................................................................. 7517 I 

2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ........................................................................................................ 7518 I 

2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) .................................................................................................. 7519 I 

2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) .................................................................................................... 7521 I 

2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) ............................................................................................. 7524 I 

2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4) .................................................................................... 7532 I 

MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 7535 I 

2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) .................................................... 7536 I 

2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) .................................................... 7537 I 

2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ......................................................... 7538 I 

Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... 7540 I 

Butylone ........................................................................................................................................................................... 7541 I 

Pentylone ......................................................................................................................................................................... 7542 I 

alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ 7545 I 

alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... 7546 I 

AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ................................................................................................... 7694 I 

Desomorphine ................................................................................................................................................................. 9055 I 

Etorphine (except HCl) .................................................................................................................................................... 9056 I 

Codeine methylbromide ................................................................................................................................................... 9070 I 

Heroin .............................................................................................................................................................................. 9200 I 

Morphine-N-oxide ............................................................................................................................................................ 9307 I 

Normorphine .................................................................................................................................................................... 9313 I 

Pholcodine ....................................................................................................................................................................... 9314 I 

U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .............................................................. 9547 I 

AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. 9551 I 

Acetylmethadol ................................................................................................................................................................ 9601 I 

Allylprodine ...................................................................................................................................................................... 9602 I 

Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... 9603 I 

Alphameprodine ............................................................................................................................................................... 9604 I 

Alphamethadol ................................................................................................................................................................. 9605 I 

Betacetylmethadol ........................................................................................................................................................... 9607 I 

Betameprodine ................................................................................................................................................................ 9608 I 

Betamethadol ................................................................................................................................................................... 9609 I 

Betaprodine ..................................................................................................................................................................... 9611 I 

Dextromoramide .............................................................................................................................................................. 9613 I 

Dipipanone ....................................................................................................................................................................... 9622 I 

Hydroxypethidine ............................................................................................................................................................. 9627 I 

Noracymethadol ............................................................................................................................................................... 9633 I 

Norlevorphanol ................................................................................................................................................................ 9634 I 

Normethadone ................................................................................................................................................................. 9635 I 

Racemoramide ................................................................................................................................................................ 9645 I 


sradovich on DSK3GMQ082PROD with NOTICES
32908 Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices 

Controlled substance Drug code Schedule 

Trimeperidine ................................................................................................................................................................... 9646 I 

1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... 9661 I 

Tilidine ............................................................................................................................................................................. 9750 I 

Para-Fluorofentanyl ......................................................................................................................................................... 9812 I 

3-Methylfentanyl .............................................................................................................................................................. 9813 I 

Alpha-methylfentanyl ....................................................................................................................................................... 9814 I 

Acetyl-alpha-methylfentanyl ............................................................................................................................................. 9815 I 

Beta-hydroxyfentanyl ....................................................................................................................................................... 9830 I 

Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ 9831 I 

Alpha-methylthiofentanyl ................................................................................................................................................. 9832 I 

3-Methylthiofentanyl ......................................................................................................................................................... 9833 I 

Thiofentanyl ..................................................................................................................................................................... 9835 I 

Methamphetamine ........................................................................................................................................................... 1105 II 

Methylphenidate .............................................................................................................................................................. 1724 II 

Amobarbital ...................................................................................................................................................................... 2125 II 

Pentobarbital .................................................................................................................................................................... 2270 II 

Secobarbital ..................................................................................................................................................................... 2315 II 

Glutethimide ..................................................................................................................................................................... 2550 II 

Nabilone ........................................................................................................................................................................... 7379 II 

1-Phenylcyclohexylamine ................................................................................................................................................ 7460 II 

Phencyclidine ................................................................................................................................................................... 7471 II 

Phenylacetone ................................................................................................................................................................. 8501 II 

1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ 8603 II 

Alphaprodine .................................................................................................................................................................... 9010 II 

Dihydrocodeine ................................................................................................................................................................ 9120 II 

Ecgonine .......................................................................................................................................................................... 9180 II 

Ethylmorphine .................................................................................................................................................................. 9190 II 

Levomethorphan .............................................................................................................................................................. 9210 II 

Levorphanol ..................................................................................................................................................................... 9220 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II 

Levo-alphacetylmethadol ................................................................................................................................................. 9648 II 

Noroxymorphone ............................................................................................................................................................. 9668 II 

Racemethorphan ............................................................................................................................................................. 9732 II 

Alfentanil .......................................................................................................................................................................... 9737 II 

Remifentanil ..................................................................................................................................................................... 9739 II 

Sufentanil ......................................................................................................................................................................... 9740 II 

Carfentanil ....................................................................................................................................................................... 9743 II 

Tapentadol ....................................................................................................................................................................... 9780 II 

The company plans to import small 

quantities of the listed controlled 

substances for the manufacture of 

analytical reference standards and 

distribution to their research and 

forensic customers. 

Dated: July 10, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–15139 Filed 7–13–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1121–NEW] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Approval of a 

New Collection; Comments Requested: 

National Survey of Victim Service 

Providers (NCVSP) 

AGENCY: Bureau of Justice Statistics, 

Department of Justice. 

ACTION: 60-day notice. 

SUMMARY: The Department of Justice 

(DOJ), Office of Justice Programs, 

Bureau of Justice Statistics, will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 60 days until 

September 14, 2018. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

especially on the estimated public 

burden or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions or 

additional information, please contact 

Barbara Oudekerk, Statistician, Bureau 

of Justice Statistics, 810 Seventh Street 

NW, Washington, DC 20531 (email: 

Barbara.a.oudekerk@usdoj.gov; 

telephone: 202–616–3904). 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the Bureau of Justice 

Statistics, including whether the 

information will have practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 


sradovich on DSK3GMQ082PROD with NOTICES